RegulatoryAlerts Logo
RegulatoryAlerts
InsightsBlogPricingSign InStart Free Trial
Back to Home
MFDS (South Korea)
NOTICE
생물학적제제 등의 품목허가ㆍ심사 규정 일부개정고시안 행정예고(제2026-150호, 2026.2.27.)
Published: 2/27/2026Detected: 3/26/2026

Summary preview

Proposes amendments to MFDS regulations governing product authorization review for biological products, signaling potential updates to how applications are prepared and assessed.

Get the full analysis, free

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

Create free account
immunology
infectious_disease
rare_diseases
pediatrics
#MFDS
#biological products
#product authorization
#regulatory review
#administrative notice

Official Source Document
Source Verified

Access the original document directly from MFDS.

View Official Document

More from MFDS (South Korea)

  • 「희소긴급도입 필요 의료기기 공급 등에 관한 규정」 일부개정고시(안) 행정예고(공고 제2026-555호)11/16/2026
  • 「의약품 병용금기 성분 등의 지정에 관한 규정」 일부개정고시안 행정예고(식품의약품안전처 공고 제2026-554호)11/16/2026
  • 「바이오의약품 원료물질 및 원료의약품의 수입절차 특례 등에 관한 규정」 제정고시안 행정예고(식품의약품안전처 공고 제 2026-553호)11/13/2026
  • 「담배의 유해성 관리에 관한 법률 시행규칙」 일부개정령안 입법예고(식품의약품안전처공고 제2026-545호)11/12/2026
  • 「생물학적제제 기준 및 시험방법」 일부개정고시(안) 행정예고 알림(공고 제2026-547호, 2026.11.9.)11/9/2026

Get MFDS (South Korea) alerts in your inbox as they are published.

Free plan, 2-minute setup, no credit card required.

RegulatoryAlerts Logo
RegulatoryAlerts

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Product

  • Insights
  • Updates by Therapeutic Area
  • FDA Updates
  • EMA Updates
  • Pricing
  • Features
  • Request Demo

Resources

  • Integration Guides
  • Regulatory Glossary
  • EMA Timeline
  • Best Practices
  • Therapeutic Areas

Company

  • About Us
  • Blog
  • Contact
  • Security
  • Privacy Policy
  • Terms of Service
  • © 2026 RegulatoryAlerts. All rights reserved.

    Not affiliated with the FDA, EMA, or Health Canada.